Harekrishna Roy
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 10%
Papers in
-
- Drug Solubulity and Delivery Systems 11
- Advanced Drug Delivery Systems 11
- Advancements in Transdermal Drug Delivery 6
- Co-authors
- Sisir Nandi (20 shared papers)Balaji Maddiboyina (12 shared papers)M. Kavisri (2 shared papers)Gandhi Sivaraman (2 shared papers)Meivelu Moovendhan (2 shared papers)Bedanta Roy (1 shared paper)Raghvendra A. Bohara (3 shared papers)Stefano Leporatti (1 shared paper)
- Journals
- Journal of Drug Delivery Science and Technology (3 papers)Current Drug Targets (2 papers)Combinatorial Chemistry & High Throughput Screening (2 papers)Current Topics in Medicinal Chemistry (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- IndiaUnited StatesIreland
In The Last Decade
Harekrishna Roy
44 papers receiving 445 citations
Peers
Comparison fields: 5 of 92
- Pharmaceutical Science 143
- Drug Discovery 2
- Molecular Medicine 36
- Biomaterials 78
- Analytical Chemistry 25
Countries citing papers authored by Harekrishna Roy
This map shows the geographic impact of Harekrishna Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harekrishna Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harekrishna Roy more than expected).
Fields of papers citing papers by Harekrishna Roy
This network shows the impact of papers produced by Harekrishna Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harekrishna Roy. The network helps show where Harekrishna Roy may publish in the future.
Co-authors
The 25 scholars most cited alongside Harekrishna Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 53 | |
| 2 | 2013 | 36 | |
| 3 | 2024 | 34 | |
| 4 | 2016 | 25 | |
| 5 | 2023 | 23 | |
| 6 | 2020 | 22 | |
| 7 | 2023 | 20 | |
| 8 | 2023 | 20 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 19 | |
| 11 | 2021 | 16 | |
| 12 | 2023 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2020 | 14 | |
| 15 | 2021 | 13 | |
| 16 | 2023 | 11 | |
| 17 | 2025 | 11 | |
| 18 | 2018 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2013 | 7 |
About Harekrishna Roy
Harekrishna Roy is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Endocrinology, Diabetes and Metabolism and Molecular Medicine, having authored 47 papers that have together received 468 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (11 papers), Advanced Drug Delivery Systems (11 papers), Advancements in Transdermal Drug Delivery (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Natural Antidiabetic Agents Studies (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Hydrogels: synthesis, properties, applications (3 papers) and Graphene and Nanomaterials Applications (3 papers). The work is most often cited by research in Pharmaceutical Science (143 citations), Drug Discovery (2 citations), Molecular Medicine (36 citations), Biomaterials (78 citations) and Analytical Chemistry (25 citations). Harekrishna Roy has collaborated with scholars based in India, United States and Ireland. Frequent co-authors include Sisir Nandi, Balaji Maddiboyina, M. Kavisri, Gandhi Sivaraman, Meivelu Moovendhan, Bedanta Roy, Raghvendra A. Bohara, Stefano Leporatti, G. Shiva Kumar and Jitendra Patel. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Current Drug Targets, Combinatorial Chemistry & High Throughput Screening, Current Topics in Medicinal Chemistry and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.